Trexquant Investment LP Abiomed Inc Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $114,212 - $141,987	-471 Reduced 3.45%	13,178 $3.24 Million
Q2 2022 Aug 11, 2022	BUY	$224.73 - $338.64 $3.07 Million - $4.62 Million	13,649 New	13,649 $3.38 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $191,200 - $236,178	-636 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $104,223 - $126,403	-336 Reduced 34.57%	636 $207,000
Q2 2021 Aug 12, 2021	BUY	$262.71 - $351.17 $255,354 - $341,337	972 New	972 $303,000
Q4 2020 Feb 11, 2021	SELL	$251.88 - $324.2 $1.6 Million - $2.06 Million	-6,347 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$255.22 - $317.0 $913,687 - $1.13 Million	3,580 Added 129.38%	6,347 $1.76 Million
Q2 2020 Aug 07, 2020	SELL	$141.4 - $257.09 $700,637 - $1.27 Million	-4,955 Reduced 64.17%	2,767 $668,000
Q1 2020 May 08, 2020	SELL	$130.51 - $196.01 $152,305 - $228,743	-1,167 Reduced 13.13%	7,722 $1.12 Million
Q4 2019 Feb 12, 2020	BUY	$159.31 - $223.54 $1.42 Million - $1.99 Million	8,889 New	8,889 $1.52 Million
Q3 2019 Nov 08, 2019	SELL	$175.89 - $279.23 $3.37 Million - $5.36 Million	-19,178 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$250.96 - $284.94 $593,520 - $673,883	2,365 Added 14.07%	19,178 $5 Million
Q1 2019 May 13, 2019	BUY	$276.39 - $362.25 $4.65 Million - $6.09 Million	16,813 New	16,813 $4.8 Million
Q3 2018 Nov 09, 2018	SELL	$354.53 - $449.75 $3.08 Million - $3.9 Million	-8,674 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$278.07 - $446.21 $2.41 Million - $3.87 Million	8,674 New	8,674 $3.55 Million
Q1 2018 May 03, 2018	SELL	$192.49 - $295.85 $1.84 Million - $2.83 Million	-9,567 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$168.78 - $199.74 $1.61 Million - $1.91 Million	9,567	9,567 $1.79 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account